Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07569302
PHASE2

Triggering Ovulation in Normo-responders Using a Modified Dual Trigger Protocol or HCG Trigger

Sponsor: Bedaya Hospital

View on ClinicalTrials.gov

Summary

The aim of this randomized controlled study is to compare the efficacy of a modified dual trigger protocol \[a single bolos of HCG combined with two successive doses of a GnRH agonist \] with HCG \[a single bolos administered 36 hours before oocyte retrieval \] in triggering ovulation in normo-responders undergoing ovarian stimulation using the antagonist protocol.

Official title: Triggering Ovulation in Normo-responders Using a Modified Dual Trigger Protocol or HCG Trigger . A Randomized Controlled Study

Key Details

Gender

FEMALE

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

196

Start Date

2026-06-01

Completion Date

2028-04-01

Last Updated

2026-05-06

Healthy Volunteers

No

Interventions

DRUG

Modified dual trigger

HCG (10000 IU /IM) and triptorelin (0.2 mg/S.C) are administered 36 hours before ovum pickup . Moreover, 0.1mg of triptorelin is administered 24 h prior to ovum pick-up.

DRUG

HCG

HCG (10000 IU/IM ) is administered 36 hours before ovum pickup.

Locations (1)

Bedaya Hospital

Giza, Giza Governorate, Egypt